{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:26:37Z","timestamp":1788485197385,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Xiamen Key Medical and Health Project","award":["3502Z20234004"],"award-info":[{"award-number":["3502Z20234004"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian provincial health technology project","doi-asserted-by":"crossref","award":["2024CXB017"],"award-info":[{"award-number":["2024CXB017"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Natural Science Foundation of China","award":["2022J02055"],"award-info":[{"award-number":["2022J02055"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271387"],"award-info":[{"award-number":["82271387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xiamen Municipal Science and Technology Bureau Technology Development Project","award":["2024350204000098"],"award-info":[{"award-number":["2024350204000098"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12012-025-10026-2","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:17:32Z","timestamp":1752502652000},"page":"1548-1560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Construction of a Machine Learning-Based Clopidogrel Resistance Risk Prediction Model"],"prefix":"10.1007","volume":"25","author":[{"given":"Ruo-Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Di","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"2","key":"10026_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-0037-1615690","volume":"85","author":"C Dangelmaier","year":"2001","unstructured":"Dangelmaier, C., Jin, J., Smith, J. B., & Kunapuli, S. P. (2001). Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Thrombosis and Haemostasis, 85(2), 341\u2013348.","journal-title":"Thrombosis and Haemostasis"},{"issue":"21","key":"10026_CR2","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jacc.2009.05.074","volume":"54","author":"JS Berger","year":"2009","unstructured":"Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., & Berger, P. B. (2009). The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. Journal of the American College of Cardiology, 54(21), 1935\u20131945. https:\/\/doi.org\/10.1016\/j.jacc.2009.05.074","journal-title":"Journal of the American College of Cardiology"},{"issue":"9281","key":"10026_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/s0140-6736(01)05701-4","volume":"358","author":"SR Mehta","year":"2001","unstructured":"Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H., Zhao, F., Chrolavicius, S., Copland, I., & Fox, K. A. (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet, 358(9281), 527\u2013533. https:\/\/doi.org\/10.1016\/s0140-6736(01)05701-4","journal-title":"Lancet"},{"issue":"10233","key":"10026_CR4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/s0140-6736(20)30325-1","volume":"395","author":"M Gimbel","year":"2020","unstructured":"Gimbel, M., Qaderdan, K., Willemsen, L., Hermanides, R., Bergmeijer, T., de Vrey, E., Heestermans, T., Tjon Joe Gin, M., Waalewijn, R., Hofma, S., den Hartog, F., Jukema, W., von Birgelen, C., Voskuil, M., Kelder, J., Deneer, V., & Ten Berg, J. (2020). Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): The randomised, open-label, non-inferiority trial. Lancet, 395(10233), 1374\u20131381. https:\/\/doi.org\/10.1016\/s0140-6736(20)30325-1","journal-title":"Lancet"},{"key":"10026_CR5","doi-asserted-by":"publisher","unstructured":"Correction to: 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). (2024). Eur Heart J, 45(13), 1145. https:\/\/doi.org\/10.1093\/eurheartj\/ehad870","DOI":"10.1093\/eurheartj\/ehad870"},{"key":"10026_CR6","doi-asserted-by":"publisher","unstructured":"Berenson A M, Hawken T N, Fort D G, Money S R, Ramee S R, Sternbergh W C, 3rd, & Bazan H A. (2023). Clopidogrel resistance is common in patients undergoing vascular and coronary interventions. Vascular, 31(1), 58\u201363. https:\/\/doi.org\/10.1177\/17085381211059394","DOI":"10.1177\/17085381211059394"},{"key":"10026_CR7","doi-asserted-by":"publisher","unstructured":"Karunawan N H, & Pinzon R T. (2021). Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease. Eur Cardiol, 16, e72. https:\/\/doi.org\/10.15420\/ecr.2021.16.PO16","DOI":"10.15420\/ecr.2021.16.PO16"},{"key":"10026_CR8","doi-asserted-by":"publisher","unstructured":"Nawaz, U., Noor, M., & Waheed, A. (2023). Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance. J Pak Med Assoc, 73(12), 2388\u20132392. https:\/\/doi.org\/10.47391\/jpma.8025","DOI":"10.47391\/jpma.8025"},{"key":"10026_CR9","doi-asserted-by":"publisher","unstructured":"Akkaif, M. A., Daud, N. A. A., Sha'aban, A., Ng, M. L., Abdul Kader, M. A. S., Noor, D. A. M., & Ibrahim, B. (2021). The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD). Molecules, 26(7), 1987. https:\/\/doi.org\/10.3390\/molecules26071987","DOI":"10.3390\/molecules26071987"},{"issue":"2","key":"10026_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06251","volume":"7","author":"W Al Awaida","year":"2021","unstructured":"Al Awaida, W., Ahmed, A. A., Hamza, A. A., Amber, K. I., Al-Ameer, H. J., Jarrar, Y., Fatima, G., Maslat, A. O., Gushchina, Y., Al Bawareed, O., & Hadi, N. R. (2021). Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention. Heliyon, 7(2), Article e06251. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06251","journal-title":"Heliyon"},{"issue":"6","key":"10026_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41401-018-0178-4","volume":"40","author":"YB Chen","year":"2019","unstructured":"Chen, Y. B., Zhou, Z. Y., Li, G. M., Xiao, C. X., Yu, W. B., Zhong, S. L., Cai, Y. F., Jin, J., & Huang, M. (2019). Influences of an NR1I2 polymorphism on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients. Acta Pharmacologica Sinica, 40(6), 762\u2013768. https:\/\/doi.org\/10.1038\/s41401-018-0178-4","journal-title":"Acta Pharmacologica Sinica"},{"issue":"6","key":"10026_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106448","volume":"31","author":"H Chen","year":"2022","unstructured":"Chen, H., Zhan, Y., Lou, Z., Mao, H., Zhang, C., Li, X., Chen, G., Ouyang, H., Huang, Z., Wen, L., Xu, H., Zheng, Z., Zhao, Y., & Zhao, M. (2022). High triglyceride is an independent predictor of high on-treatment platelet reactivity in ischemic stroke patients. Journal of Stroke and Cerebrovascular Diseases, 31(6), Article 106448. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2022.106448","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10026_CR13","doi-asserted-by":"publisher","unstructured":"Lim, I. H., Lee, S. J., Shin, B. S., & Kang, H. G. (2022). Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients. Biomedicines, 10(6), 1366. https:\/\/doi.org\/10.3390\/biomedicines10061366","DOI":"10.3390\/biomedicines10061366"},{"key":"10026_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652416","volume":"12","author":"HG Kang","year":"2021","unstructured":"Kang, H. G., Lee, S. J., Heo, S. H., Chang, D. I., & Kim, B. J. (2021). Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment. Frontiers in Neurology, 12, Article 652416. https:\/\/doi.org\/10.3389\/fneur.2021.652416","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10026_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/hco.0000000000000624","volume":"34","author":"K Pafili","year":"2019","unstructured":"Pafili, K., Penlioglou, T., Mikhailidis, D. P., & Papanas, N. (2019). Mean platelet volume and coronary artery disease. Current Opinion in Cardiology, 34(4), 390\u2013398. https:\/\/doi.org\/10.1097\/hco.0000000000000624","journal-title":"Current Opinion in Cardiology"},{"issue":"2","key":"10026_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40291-023-00691-w","volume":"28","author":"HG Xie","year":"2024","unstructured":"Xie, H. G., Jiang, L. P., Tai, T., Ji, J. Z., & Mi, Q. Y. (2024). The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BP\u03b1 as a Biomarker to Predict Clopidogrel Resistance. Molecular Diagnosis & Therapy, 28(2), 189\u2013199. https:\/\/doi.org\/10.1007\/s40291-023-00691-w","journal-title":"Molecular Diagnosis & Therapy"},{"key":"10026_CR17","doi-asserted-by":"publisher","unstructured":"Qin L, Liang Z, Xie J, Ye G, Guan P, Huang Y, & Li X. (2023). Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study. J Gastrointest Oncol, 14(1), 220\u2013232. https:\/\/doi.org\/10.21037\/jgo-23-18","DOI":"10.21037\/jgo-23-18"},{"key":"10026_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.107582","volume":"237","author":"X Li","year":"2023","unstructured":"Li, X., Xu, C., Shang, C., Wang, Y., Xu, J., & Zhou, Q. (2023). Machine learning predicts the risk of hemorrhagic transformation of acute cerebral infarction and in-hospital death. Computer Methods and Programs in Biomedicine, 237, Article 107582. https:\/\/doi.org\/10.1016\/j.cmpb.2023.107582","journal-title":"Computer Methods and Programs in Biomedicine"},{"key":"10026_CR19","doi-asserted-by":"publisher","first-page":"107602962110732","DOI":"10.1177\/10760296211073272","volume":"28","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Dong, Z. F., Bian, C. X., Zhang, X., Xin, X. B., & Chen, F. (2022). The Correlation Between MDR1 Gene Polymorphism and Clopidogrel Resistance in People of the Hui and Han Nationalities. Clinical and Applied Thrombosis\/Hemostasis, 28, 10760296211073272. https:\/\/doi.org\/10.1177\/10760296211073272","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10026_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.576046","volume":"11","author":"Y Sun","year":"2020","unstructured":"Sun, Y., Lu, Q., Tao, X., Cheng, B., & Yang, G. (2020). Cyp2C19*2 Polymorphism Related to Clopidogrel Resistance in Patients With Coronary Heart Disease, Especially in the Asian Population: A Systematic Review and Meta-Analysis. Frontiers in Genetics, 11, Article 576046. https:\/\/doi.org\/10.3389\/fgene.2020.576046","journal-title":"Frontiers in Genetics"},{"key":"10026_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.thromres.2024.02.010","volume":"236","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Ran, Q., Yin, K., Wang, Y., Liu, J., Zong, Y., Wang, Y., & Cao, Y. (2024). The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort study. Thrombosis Research, 236, 37\u201350. https:\/\/doi.org\/10.1016\/j.thromres.2024.02.010","journal-title":"Thrombosis Research"},{"key":"10026_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jocn.2020.04.038","volume":"76","author":"J Gairolla","year":"2020","unstructured":"Gairolla, J., Ahluwalia, J., Khullar, M., Kler, R., Kishore, K., Medhi, B., Modi, M., Kumar, M., Kumar, A., & Khurana, D. (2020). Clopidogrel response in ischemic stroke patients: Is polymorphism or gender more important? Results of the CRISP study. Journal of Clinical Neuroscience, 76, 81\u201386. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.038","journal-title":"Journal of Clinical Neuroscience"},{"issue":"5","key":"10026_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2174\/1570161112666141017121118","volume":"13","author":"YY Koh","year":"2015","unstructured":"Koh, Y. Y., Kim, H. H., Choi, D. H., Lee, Y. M., Ki, Y. J., Kang, S. H., Park, G., Chung, J. W., Chang, K. S., & Hong, S. P. (2015). Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention. Current Vascular Pharmacology, 13(5), 687\u2013693. https:\/\/doi.org\/10.2174\/1570161112666141017121118","journal-title":"Current Vascular Pharmacology"},{"issue":"1","key":"10026_CR24","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1038\/s41598-022-09679-8","volume":"12","author":"S Ahmed","year":"2022","unstructured":"Ahmed, S., Gul, S., Siraj, S., Hussain, A., Sheikh, F. S., Shah, S. U., Janjua, K., Khan, H., & Hamdard, M. H. (2022). Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients. Science and Reports, 12(1), 6171. https:\/\/doi.org\/10.1038\/s41598-022-09679-8","journal-title":"Science and Reports"},{"issue":"3","key":"10026_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","volume":"4","author":"V Faure","year":"2006","unstructured":"Faure, V., Dou, L., Sabatier, F., Cerini, C., Sampol, J., Berland, Y., Brunet, P., & Dignat-George, F. (2006). Elevation of circulating endothelial microparticles in patients with chronic renal failure. Journal of Thrombosis and Haemostasis, 4(3), 566\u2013573. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01780.x","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10026_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.11.014","volume":"85","author":"MG Abrignani","year":"2021","unstructured":"Abrignani, M. G., Gatta, L., Gabrielli, D., Milazzo, G., De Francesco, V., De Luca, L., Francese, M., Imazio, M., Riccio, E., Rossini, R., Scotto di Uccio, F., Soncini, M., Zullo, A., Colivicchi, F., Di Lenarda, A., Gulizia, M. M., & Monica, F. (2021). Gastroprotection in patients on antiplatelet and\/or anticoagulant therapy: A position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). European Journal of Internal Medicine, 85, 1\u201313. https:\/\/doi.org\/10.1016\/j.ejim.2020.11.014","journal-title":"European Journal of Internal Medicine"},{"issue":"8","key":"10026_CR27","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","volume":"24","author":"AI Vinik","year":"2001","unstructured":"Vinik, A. I., Erbas, T., Park, T. S., Nolan, R., & Pittenger, G. L. (2001). Platelet dysfunction in type 2 diabetes. Diabetes Care, 24(8), 1476\u20131485. https:\/\/doi.org\/10.2337\/diacare.24.8.1476","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10026-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-10026-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10026-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T03:11:32Z","timestamp":1757646692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-10026-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10026"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-10026-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Xiamen University Medical College Affiliated Zhongshan Hospital (No. 2024-045) and was conducted in accordance with national regulations and the principles of the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}